查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1656909

防回流设备的全球市场:洞察，竞争情形，市场预测:2032年

Anti-retropulsion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计在预测期内，即 2025-2032 年，防回流装置市场规模将以 6.69% 的复合年增长率扩大。预防逆流设备的需求不断增加，主要是由于肾结石发病率不断上升，而肾结石通常与脱水等因素有关。此外，良性前列腺增生 (BPH)、肥胖和久坐的生活方式等风险因素负担的增加（这些是肾结石发展的关键风险因素）进一步促进了市场的成长。防回流装置的技术进步以及主要参与者的持续研发努力也在推动预测期（即 2025-2032 年）防回流装置市场积极成长方面发挥关键作用。

肾结石（尿石症）盛行率的上升是推动逆流预防设备市场扩张的关键因素。根据英国肾臟研究中心 2023 年 10 月的数据，英国大约每 10 人就有 1 人患有肾结石。

根据加拿大泌尿科 2023 年的数据，加拿大大约每 10 人中就有 1 人在一生中的某个阶段会患上肾结石。该病在男性中比女性更常见，并且各个地区的活跃病例都在增加。肾结石发病率的不断上升推动了相关医疗器材和治疗市场的成长。防逆流装置在肾结石的治疗中发挥重要作用，尤其是在输尿管镜检查和碎石术等手术过程中。这些装置是专门为防止结石碎片在治疗过程中返回肾臟而设计的。由于全球肾结石病例不断增加，对包括反流预防装置在内的先进医疗解决方案的需求预计将持续上升，进一步促进市场的扩张。

肥胖和久坐的生活方式的增加是肾结石的主要风险因素，进一步推动了市场的成长。根据世界卫生组织（WHO）2024年2月的数据，到2022年肥胖将影响全球超过10亿人，其中包括6.5亿成年人、3.4亿青少年和3,900万名儿童。预计这一数字将继续增长，增加对肾结石治疗的需求，从而推动市场成长。

然而，设备相关併发症风险、熟练专业人员短缺以及低收入国家获得抗逆流设备的有限等挑战可能会成为市场成长的限制因素。

本报告提供全球防回流设备市场相关调查，提供市场概要，以及各产品类型，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 抗逆流设备市场报告的简介

第2章 防回流设备市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 抗逆流设备市场主要原因分析

  • 防回流设备市场促进因素
  • 防回流设备市场阻碍因素与课题
  • 防回流设备市场机会

第6章 防回流设备市场上波特的五力分析

第7章 逆喷射防止设备的市场评估

  • 各产品类型
    • 结石捕获和提取装置
    • 结石回收装置
    • 其他
  • 各终端用户
    • 医院
    • 门诊病人手术中心
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 防回流设备市场企业与产品简介

  • Boston Scientific Corporation
  • Cook
  • Rocamed
  • Accordion Medical
  • EndoTheia, Inc.
  • KARL STORZ
  • Olympus Corporation
  • Coloplast Group
  • Endotherapeutics Pty Ltd.
  • ELMED Medical Systems
  • PENTAX Medical
  • UROMED Kurt Drews KG
  • BD
  • Dornier MedTech
  • NeoScope Inc.
  • OTU Medical
  • Clarion Medical Technologies
  • Calyxo, Inc.
  • EMS Urology
  • Happiness Works Medical

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0394

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 due to the growing prevalence of kidney stones and increasing R&D activiites and product launches in anti-retropulsion devices.

The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032. The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

Anti-retropulsion Devices Market Dynamics:

The growing prevalence of kidney stones (urolithiasis) is a key factor driving the expansion of the anti-retropulsion devices market. According to Kidney Research UK data from October 2023, kidney stones affect approximately one in ten individuals in the United Kingdom.

According to data from the Canadian Urological Association in 2023, approximately one in ten people develop a kidney stone at some point in their life in Canada. This condition is more prevalent in men than in women, with active cases on the rise in various regions. This increasing incidence of kidney stones is driving the growth of the market for related medical devices and treatments. Anti-retropulsion devices play a critical role in the management of kidney stones, particularly during procedures like ureteroscopy and lithotripsy. These devices are specifically designed to prevent the migration of stone fragments back into the kidney during treatment. With the growing number of kidney stone cases worldwide, the demand for advanced medical solutions, including anti-retropulsion devices, is expected to continue rising, further contributing to the market's expansion.

The growing incidence of obesity and sedentary lifestyles-key risk factors for kidney stones-further drives market growth. According to the World Health Organization (WHO) in February 2024, over 1 billion people worldwide were affected by obesity in 2022, including 650 million adults, 340 million adolescents, and 39 million children. This number is expected to rise, creating a greater demand for kidney stone treatments, thereby driving the market growth.

However, challenges such as the risk of device-related complications, lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries may act as barriers to market growth.

Anti-retropulsion Devices Market Segment Analysis:

Anti-retropulsion Devices Market by Product Type (Stone Entrapment and Extraction Devices, Stone Retrieval Devices, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the anti-retropulsion devices, stone entrapment and extraction devices are expected to capture the largest market share during the forecast period. The is attributed to various advantages associated with these devices. Stone entrapment and extraction devices are highly effective tools for removing kidney stones from the urinary tract, while also minimizing the risk of stone migration.

These devices offer minimally invasive solutions, meaning smaller incisions or no incisions at all, which results in less pain, a lower risk of infection, and quicker recovery times compared to traditional open surgery. For larger stones or those located in difficult-to-reach areas, stone extraction through entrapment proves to be particularly beneficial. These devices are designed to fragment stones into smaller pieces, making them easier to remove or pass naturally, reducing the need for more invasive procedures. This approach not only improves patient comfort but also contributes to more efficient treatment outcomes, promoting faster recovery and preserving overall kidney function.

Stone entrapment and extraction devices also play a crucial role in preventing the proximal migration of stones and fragments during ureteroscopy. This is essential for maintaining visibility and access to the stone, ensuring that the procedure is efficient and reduces the risk of complications associated with stone migration back into the kidney. For instance, devices like the EscapeTM Nitinol Stone Retrieval Device by Boston Scientific are specifically designed to facilitate smoother procedures by minimizing retropulsion, a common issue that can lead to longer operative times and increased procedure complexity.

In addition, the innovative technologies within the stone entrapment and extraction devices category, combined with their growing applications in urological procedures, are expected to significantly drive market growth. As the demand for more effective treatment solutions increases, the anti-retropulsion devices market is set to expand further throughout the forecast period.

North America is expected to dominate the overall anti-retropulsion devices market:

North America is projected to dominate the anti-retropulsion devices market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

According to data from the American Kidney Fund (2024), over 1 in 10 men and approximately 1 in 14 women in the United States experienced kidney stones at least once in their lifetime. Additionally, data from the National Institutes of Health (NIH) in 2023 highlighted that kidney stone affects 1 in 11 people, with an estimated 600,000 new cases reported in the United States annually. The rising prevalence of kidney stones is significantly driving the growth of the anti-retropulsion devices market in the region.

The increasing incidence of upper tract urothelial carcinoma (UTUC) and kidney diseases is also a significant driver for the growing demand for anti-retropulsion devices. Patients with urinary cancers and other urinary tract conditions face an elevated risk of developing renal stones, exacerbating the need for effective anti-retropulsion interventions. According to data from the Center for Disease Control and Prevention (CDC) published in June 2024, approximately 35 million cases of chronic kidney disease (CKD) were reported in the United States in 2023. CKD impairs kidney function, leading to the formation and accumulation of renal stones, thereby fueling demand for anti-retropulsion devices and promoting market expansion.

Anti-retropulsion Devices Market Key Players:

Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

Recent Developmental Activities in the Anti-retropulsion Devices Market:

  • In November 2024, EndoTheia, Inc., a frontrunner in innovative surgical technology, announced the successful completion of the first-in-human clinical trial for its FlexStone(TM) Basket. The cutting-edge device provides unmatched flexibility and control, allowing for the retrieval of stones from difficult-to-reach and challenging locations, thereby enhancing the precision and effectiveness of stone removal procedures. The success of this trial marked a significant milestone in advancing minimally invasive treatments for kidney stones.

Key Takeaways from the Anti-retropulsion Devices Market Report Study

  • Market size analysis for current Anti-retropulsion Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the Anti-retropulsion Devices market.
  • Various opportunities are available for the other competitors in the Anti-retropulsion Devices Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Anti-retropulsion Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Anti-retropulsion Devices market growth in the coming future?

Target Audience who can be benefited from this Anti-retropulsion Devices Market Report Study

  • Anti-retropulsion Devices product providers
  • Research organizations and consulting companies
  • Anti-retropulsion Devices related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Anti-retropulsion Devices
  • Various end-users who want to know more about the Anti-retropulsion Devices Market and the latest technological developments in the Anti-retropulsion Devices Market.

Frequently Asked Questions for the Anti-retropulsion Devices Market:

1. What are Anti-retropulsion Devices?

  • Anti-retropulsion devices for kidney stones are medical instruments designed to prevent the backward movement (retropulsion) of kidney stones during minimally invasive procedures, such as ureteroscopy or lithotripsy. When a stone is being fragmented or removed, there is a risk that it could move away from the targeted area, potentially causing complications or making the procedure less effective.

2. What is the market for ureteroscopes?

  • The anti-retropulsion devices market is estimated to grow at a CAGR of 6.69% during the forecast period from 2025 to 2032.

3. What are the drivers for the Anti-retropulsion Devices market?

  • The increasing demand for anti-retropulsion devices is primarily driven by the rising prevalence of kidney stones which are often linked to factors like dehydration. Additionally, the growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles, both of which are significant risk factors for the development of kidney stones, further contribute to the market's growth. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players, are also playing a pivotal role in propelling the positive growth of the anti-retropulsion devices market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the Anti-retropulsion Devices market?

  • Some of the key market players operating in the anti-retropulsion devices market include Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.

5. Which region has the highest share in the Anti-retropulsion Devices market?

  • North America is projected to dominate the ureteroscope market during the forecast period from 2025 to 2032. This growth can be attributed to several critical drivers, including the increasing incidence of kidney stones and urinary cancers, as well as a rise in risk factors associated with kidney stone formation. Furthermore, advancements in technology related to the development of anti-retropulsion devices, coupled with a strong healthcare infrastructure, are expected to significantly propel market expansion in the region.

Table of Contents

1. Anti-retropulsion Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Anti-retropulsion Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Anti-retropulsion Devices Market Key Factors Analysis

  • 5.1. Anti-retropulsion Devices Market Drivers
    • 5.1.1. The growing prevalence of kidney stones
    • 5.1.2. The growing burden of risk factors such as benign prostatic hyperplasia (BPH), obesity, and sedentary lifestyles
    • 5.1.3. Technological advancements in anti-retropulsion devices, along with ongoing research and development efforts by key players
  • 5.2. Anti-retropulsion Devices Market Restraints and Challenges
    • 5.2.1. Risks of device-associated complications
    • 5.2.2. Lack of skilled professionals, and limited access to anti-retropulsion devices in low-income countries
  • 5.3. Anti-retropulsion Devices Market Opportunity
    • 5.3.1. Shift towards minimally invasive procedures

6. Anti-retropulsion Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Anti-retropulsion Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Stone Entrapment and Extraction Devices
    • 7.1.2. Stone Retrieval Devices
    • 7.1.3. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.1.2. Canada Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.1.3. Mexico Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.2. Europe
      • 7.3.2.1. France Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.2. Germany Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.3. United Kingdom Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.4. Italy Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.5. Spain Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.2.6. Rest of Europe Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.2. Japan Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.3. India Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.4. Australia Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.5. South Korea Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.3.6. Rest of Asia-Pacific Anti-retropulsion Devices Market Size in USD million (2022-2032)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.4.2. Africa Anti-retropulsion Devices Market Size in USD million (2022-2032)
      • 7.3.4.3. South America Anti-retropulsion Devices Market Size In USD Million (2022-2032)

8. Anti-retropulsion Devices Market Company and Product Profiles

  • 8.1. Boston Scientific Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Cook
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Rocamed
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Accordion Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. EndoTheia, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. KARL STORZ
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Olympus Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Coloplast Group
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Endotherapeutics Pty Ltd.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. ELMED Medical Systems
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. PENTAX Medical
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. UROMED Kurt Drews KG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. BD
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Dornier MedTech
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. NeoScope Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. OTU Medical
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Clarion Medical Technologies
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Calyxo, Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. EMS Urology
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Happiness Works Medical
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Anti-retropulsion Devices Market in Global (2022-2032)
  • Table 3: Anti-retropulsion Devices Market in Global by Product Type (2022-2032)
  • Table 4: Anti-retropulsion Devices Market in Global by End-User (2022-2032)
  • Table 5: Anti-retropulsion Devices Market in Global by Geography (2022-2032)
  • Table 6: Anti-retropulsion Devices Market in North America (2022-2032)
  • Table 7: Anti-retropulsion Devices Market in the United States (2022-2032)
  • Table 8: Anti-retropulsion Devices Market in Canada (2022-2032)
  • Table 9: Anti-retropulsion Devices Market in Mexico (2022-2032)
  • Table 10: Anti-retropulsion Devices Market in Europe (2022-2032)
  • Table 11: Anti-retropulsion Devices Market in France (2022-2032)
  • Table 12: Anti-retropulsion Devices Market in Germany (2022-2032)
  • Table 13: Anti-retropulsion Devices Market in United Kingdom (2022-2032)
  • Table 14: Anti-retropulsion Devices Market in Italy (2022-2032)
  • Table 15: Anti-retropulsion Devices Market in Spain (2022-2032)
  • Table 16: Anti-retropulsion Devices Market in Rest of Europe (2022-2032)
  • Table 17: Anti-retropulsion Devices Market in Asia-Pacific (2022-2032)
  • Table 18: Anti-retropulsion Devices Market in China (2022-2032)
  • Table 19: Anti-retropulsion Devices Market in Japan (2022-2032)
  • Table 20: Anti-retropulsion Devices Market in India (2022-2032)
  • Table 21: Anti-retropulsion Devices Market in Australia (2022-2032)
  • Table 22: Anti-retropulsion Devices Market in South Korea (2022-2032)
  • Table 23: Anti-retropulsion Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 24: Anti-retropulsion Devices Market in the Rest of the World (2022-2032)
  • Table 25: Anti-retropulsion Devices Market in the Middle East (2022-2032)
  • Table 26: Anti-retropulsion Devices Market in Africa (2022-2032)
  • Table 27: Anti-retropulsion Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Anti-retropulsion Devices Market in Global (2022-2032)
  • Figure 3: Anti-retropulsion Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Anti-retropulsion Devices Market in Global by End-User (2022-2032)
  • Figure 5: Anti-retropulsion Devices Market in Global by Geography (2022-2032)
  • Figure 6: Anti-retropulsion Devices Market in North America (2022-2032)
  • Figure 7: Anti-retropulsion Devices Market in the United States (2022-2032)
  • Figure 8: Anti-retropulsion Devices Market in Canada (2022-2032)
  • Figure 9: Anti-retropulsion Devices Market in Mexico (2022-2032)
  • Figure 10: Anti-retropulsion Devices Market in Europe (2022-2032)
  • Figure 11: Anti-retropulsion Devices Market in France (2022-2032)
  • Figure 12: Anti-retropulsion Devices Market in Germany (2022-2032)
  • Figure 13: Anti-retropulsion Devices Market in United Kingdom (2022-2032)
  • Figure 14: Anti-retropulsion Devices Market in Italy (2022-2032)
  • Figure 15: Anti-retropulsion Devices Market in Spain (2022-2032)
  • Figure 16: Anti-retropulsion Devices Market in Rest of Europe (2022-2032)
  • Figure 17: Anti-retropulsion Devices Market in Asia-Pacific (2022-2032)
  • Figure 18: Anti-retropulsion Devices Market in China (2022-2032)
  • Figure 19: Anti-retropulsion Devices Market in Japan (2022-2032)
  • Figure 20: Anti-retropulsion Devices Market in India (2022-2032)
  • Figure 21: Anti-retropulsion Devices Market in Australia (2022-2032)
  • Figure 22: Anti-retropulsion Devices Market in South Korea (2022-2032)
  • Figure 23: Anti-retropulsion Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 24: Anti-retropulsion Devices Market in the Rest of the World (2022-2032)
  • Figure 25: Anti-retropulsion Devices Market in the Middle East (2022-2032)
  • Figure 26: Anti-retropulsion Devices Market in Africa (2022-2032)
  • Figure 27: Anti-retropulsion Devices Market in South America (2022-2032)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis